Events and Presentations
Upcoming Events
April 14, 2020
8:00 AM EDT
8:00 AM EDT
April 15, 2020
10:40 AM EDT
10:40 AM EDT
Past Events
November 13, 2019
11:45 AM EST
11:45 AM EST
November 6, 2019
8:00 AM EST
8:00 AM EST
September 12, 2019
8:00 AM EDT
8:00 AM EDT
September 4, 2019
9:40 AM EDT
9:40 AM EDT
August 7, 2019
8:00 AM EDT
8:00 AM EDT
June 3, 2019
8:00 AM EDT
8:00 AM EDT
May 8, 2019
8:00 AM EDT
8:00 AM EDT
May 7, 2019
9:00 AM EDT
9:00 AM EDT
March 6, 2019
8:00 AM EST
8:00 AM EST
February 12, 2019
5:00 PM EST
5:00 PM EST
Corporate Presentation
Pipeline Program Detail
Scientific & Medical Meetings
|
October 16, 2019
|
Source
mRNA Medicines to Enable Intracellular, Membrane-Bound, and Extracellular Secreted Therapeutics
|
Zaks OTS 2019.pdf 4.7 MB
|
|
October 2, 2019
|
Source
Phase 1 Trial of an mRNA-based Combination Vaccine Against hMPV and PIV3
|
|
|
June 1, 2019
|
Source
A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects With Resected Solid Tumors and in Combination With Pembrolizumab in Subjects With Unresectable Solid Tumors (Keynote-603)
|
|
|
June 1, 2019
|
Source
A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects With Resected Solid Tumors and in Combination With Pembrolizumab in Subjects With Unresectable Solid Tumors (Keynote-603)
|